E
Evoke Pharma, Inc. EVOK
$10.69 $0.060.56% NASDAQ
Recommendation
Prev Close
$10.69
Volume
54,104
Avg Vol (90D)
1,785,684
Market Cap
$22.31M
Dividend & Yield
--
52-Week Range
$1.94 - $10.79
P/E (TTM)
--
EPS (TTM)
-$2.41
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Evoke Pharma just downgraded at Laidlaw, here's why
11/6/2025 - The Fly
Halper Sadeh LLC Encourages DENN, EVOK, ODP Shareholders to Contact the Firm to Discuss Their Rights
11/6/2025 - Globe Newswire
Halper Sadeh LLC Encourages HBAN, FFWM, EVOK Shareholders to Contact the Firm to Discuss Their Rights
11/5/2025 - PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Evoke Pharma, ...
11/4/2025 - GuruFocus
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Evoke Pharma, Inc. (NASDAQ: EVOK)
11/4/2025 - Globe Newswire
Shareholder Alert: The Ademi Firm investigates whether Evoke Pharma Inc. ...
11/4/2025 - GuruFocus
Shareholder Alert: The Ademi Firm investigates whether Evoke Pharma Inc. is obtaining a Fair Price for its Public Shareholders
11/4/2025 - PR Newswire
EVOK Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Evoke Pharma, Inc. ...
11/4/2025 - GuruFocus
Evoke Pharma Rockets On Grabbing 140% Premium In Acquisition Deal
11/4/2025 - Benzinga
EVOK Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Evoke Pharma, Inc. is Fair to Shareholders
11/4/2025 - Business Wire
Evoke Pharma (EVOK) Soars Over 130% on Acquisition News
11/4/2025 - GuruFocus
Evoke Pharma soars on announcement to be acquired by QOL Medical
11/4/2025 - Seeking Alpha - Healthcare
QOL Medical to Acquire Evoke Pharma (EVOK) at Significant Premium
11/4/2025 - GuruFocus
QOL Medical to acquire Evoke Pharma for $11.00 per share in cash
11/4/2025 - The Fly
Evoke Pharma Enters into Definitive Agreement to Be Acquired by QOL Medical
11/4/2025 - GuruFocus
Evoke Pharma Enters into Definitive Agreement to Be Acquired by QOL Medical
11/4/2025 - Globe Newswire
Evoke Pharma (NASDAQ:EVOK) Stock Price Crosses Above 50-Day Moving Average - Here's Why
11/4/2025 - Ticker Report
Analysts Expect Breakeven For Evoke Pharma, Inc. (NASDAQ:EVOK) Before Long
10/28/2025 - Simply Wall St
Does Omnicell's (OMCL) Expanded Gastro Network Signal a Shift in Its Specialty Pharmacy Strategy?
9/8/2025 - Simply Wall St
Evoke Pharma (NASDAQ:EVOK) vs. Supernus Pharmaceuticals (NASDAQ:SUPN) Critical Comparison
9/1/2025 - Zolmax
Does Omnicell's (OMCL) GIMOTI Partnership and CFO Transition Signal a Shift in Strategic Focus?
8/28/2025 - Simply Wall St
Evoke Pharma, EVERSANA expand GIMOTI access with Omnicell relationship
8/26/2025 - TipRanks Financial Blog
Evoke Pharma, EVERSANA expand GIMOTI access with Omnicell relationship
8/26/2025 - The Fly
Evoke Pharma and EVERSANA Expand GIMOTI Access to Gastro Health and Other Large GI Practices through Omnicell Relationship
8/26/2025 - Globe Newswire
Evoke Pharma announces listing of new GIMOTI patent in FDA Orange Book
8/21/2025 - The Fly
Income Statement
Total Revenue (TTM)
$12.79M
EBITDA (TTM)
--
EBIT (TTM)
-$5.34M
Net Income (TTM)
-$5.38M
Balance Sheet
Total Assets (Q)
$16.06M
Total Debt (Q)
$5.13M
Total Liabilities (Q)
$11.69M
Book Value Per Share (Q)
$2.16
Cash Flow
Cash from Operations (TTM)
-$3.62M
Cash from Investing (TTM)
--
Cash from Financing (TTM)
$6.50M
Net Change in Cash (TTM)
$2.88M
Filings
Filing Date
Thursday, August 14, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 3 and 7 (est)
Price History
Loading...
Beta
0.14
7-Day Total Return
110.02%
30-Day Total Return
121.78%
60-Day Total Return
108.79%
90-Day Total Return
293.01%
Year to Date Total Return
139.15%
1-Year Total Return
89.20%
2-Year Total Return
-23.20%
3-Year Total Return
-44.67%
5-Year Total Return
-97.82%
52-week Low
Apr 15, 2025 - $1.94
52-week High
Nov 04, 2025 - $10.79
Valuation
Market Cap
$22.31M - Nano Cap
Enterprise Value
$15.38M
Price/Sales (TTM)
2.13
Price/Book (Q)
4.94
Dividends and Shares
Shares Outstanding
2.55
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.evokepharma.com
Phone Number
858 345 1494
Address
420 Stevens Avenue
Solana Beach, CA 92075
Country
United States
Year Founded
2007
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Evoke Pharma, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases... more
NASDAQ 11/07/2025 4:00PM Eastern Quotes delayed